v3.25.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jul. 31, 2025
Jul. 31, 2024
Operating activities:    
Net income (loss) $ 27,521 $ (7,874)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization expense 13,643 5,814
Bad debt expense 953 363
Stock-based compensation expense 25,621 24,398
Amortization of operating lease right-of-use assets 4,683 4,265
Adjustments to contingent consideration (21,600) 0
Other, net 664 481
Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in business acquisitions:    
Accounts receivable 47,282 62,021
Prepaid expenses and other current assets (2,017) (3,231)
Costs to obtain revenue contracts 7,004 7,619
Other long term assets 6,847 215
Accounts payable, accrued expenses and other current liabilities 65 (4,649)
Unearned revenue (46,452) (56,370)
Operating lease liabilities (7,022) (5,742)
Other long term liabilities (11,060) 350
Net cash provided by operating activities 46,132 27,660
Investing activities:    
Capital expenditures (1,135) (1,192)
Cash paid in acquisitions, net of cash acquired (18,801) 0
Net cash used in investing activities (19,936) (1,192)
Financing activities:    
Proceeds from exercise of stock options 439 791
Proceeds from debt issuance 99,000 0
Repurchase of common stock (45,380) (201)
Payments for taxes related to net share settlement of stock-based compensation awards (14,002) (3,781)
Payments of deferred financing costs (877) (659)
Proceeds, net from employee stock purchase plan withholdings 1,568 1,842
Net cash provided by (used in) financing activities 40,748 (2,008)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 3,940 179
Net increase in cash, cash equivalents and restricted cash 70,884 24,639
Cash, cash equivalents and restricted cash at beginning of period 138,654 210,184
Cash, cash equivalents and restricted cash at end of period $ 209,538 $ 234,823